CITIGROUP INC

Position in ANTX — AN2 Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in ANTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$59,371

-$5,909 QoQ

Shares Held

12,267

-35.7% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 66 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ANTX ranks #291 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	706,968	$351,172,214
2	REGN	Regeneron Pharmaceuticals, Inc.	346,637	$216,142,034
3	MRNA	Moderna, Inc.	2,165,414	$151,643,941
4	ROIV	Roivant Sciences Ltd.	2,225,190	$78,749,472
5	ALNY	Alnylam Pharmaceuticals, Inc.	227,786	$68,570,419
6	INCY	Incyte Corp	586,431	$66,477,817
7	BBIO	BridgeBio Pharma, Inc.	864,101	$64,358,241
8	RVMD	Revolution Medicines, Inc.	247,052	$46,267,897

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$59,371	12,267	-35.7%	Shares	Defined	2026-08-03
2026-03-31	$65,280	19,088	-49.6%	Shares	Defined	2026-05-11
2024-06-30	$81,457	37,887	-46.5%	Shares	Defined	2024-08-12
2024-03-31	$230,122	70,807	-55.9%	Shares	Defined	2024-05-10
2023-12-31	$3,288,358	160,486	+0.9%	Shares	Defined	2024-02-09
2023-09-30	$2,558,408	159,105	+18.3%	Shares	Defined	2023-12-06
2023-06-30	$1,143,020	134,473	0.0%	Shares	Defined	2023-08-10
2023-03-31	$1,327,248	134,473	-0.1%	Shares	Defined	2023-05-11
2022-12-31	$1,282,242	134,548	+0.0%	Shares	Defined	2023-02-09
2022-09-30	$2,338,392	134,545	+53.3%	Shares	Defined	2022-11-10
2022-06-30	$680,256	87,775	—	Shares	Defined	2022-08-10
No filing history on record for this holder in this stock.